newsfilter
← Latest News
GlobeNewswire·

Scopus BioPharma Sends Letter Urging Stockholders to Vote "FOR ALL" of the Company's Director Nominees on the WHITE Proxy Card

Company's Director Nominees are Highly Qualified and Experienced with Track Records of Guiding Early-Stage Life Science Companies Executing Strategy to Create an Industry-Leading Portfolio of Bi-Functional Cancer Targeting Molecules Recently Raised